1. Home
  2. Browse
  3. Renal & Urology
  4. Drug Use in Renal Insufficiency
  5. Endocrinology

Endocrinology

31 - 45 of 46 Results
Sort Results:
Other: SGLT2 Inhibitors (Flozins) and Ketoacidosis/Urinary Tract Infections (Dec 2015) July 2015
Article: Use eGFR Instead of Cockcroft Gault for "Flozin" Dosing February 2015
Article: Advise Taking "Flozins" in the Morning October 2014
PL Voices: Role of SGLT2 Inhibitors for Type 2 Diabetes October 2014
Article: Farxiga (far-SEE-guh) for type 2 diabetes will soon hit shelves March 2014
Article: Sliding scale insulin is still giving patients a ride on the blood glucose roller coaster January 2014
Article: Experts will debate whether gliptins (Onglyza, etc) increase cardiovascular risk in patients with type 2 diabetes November 2013
PL Voices: Gliptins and Cardiovascular Risk November 2013
Article: Nesina (nes-SEE-na, alogliptin) will compete in a crowded market of gliptins, or DPP-4 inhibitors, for type 2 diabetes August 2013
Article: Invokana (in-vo-KAHN-uh, canagliflozin), the first in a new class of oral drugs for type 2 diabetes May 2013
Commentary: New Drug: Invokana (Canagliflozin) May 2013
Article: About 25% of your patients over age 65 have type 2 diabetes November 2012
PL Voices: Managing Type 2 Diabetes in Elderly Patients November 2012
Article: new option for adjusting medications in adults with kidney disease October 2009
Article: metformin is no longer contraindicated in patients with heart failure February 2008